CStone Pharma shares jump after academic recognition of its lung-cancer treatment 19-Jun-2023 By Isabel Cameron CStone Pharmaceuticals' shares have risen after academic journal Nature Cancer published the clinical study results of its lung-cancer treatment sugemalimab.
US FDA approves expanded label for Merck’s Keytruda as first-line treatment for NSCLC 22-Aug-2018 By Maggie Lynch The US FDA has approved an expanded label for Merck’s Keytruda in combination with pemetrexed and platinum chemotherapy.